-transparent.png){kind=logo}
The treatment of the acute lymphoblastic leukemia in childhood includes frequent administration of L-asparaginase by intravenous route. L-asparaginase is an enzyme produced by E. coli and Erwinia chrysanthemi strains. Adverse reactions produced by L-asparaginase are numerous, and pancreatitis is being the most severe. Children with the acute lymphoblastic leukemia were followed up for 2 years. Hyperglycaemia and glycosuria were noted in 10% of them resulting in L-asparaginase cessation or replacement by less toxic agents. The acute pancreatitis was produced in 8% of the patients, and was treated typically.
Related Publications
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
October 2009,
Journal of pediatric hematology/oncology,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
January 2022,
Leukemia research reports,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
August 2022,
Pediatric research,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
September 2010,
Pediatric hematology and oncology,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
January 1989,
Developmental pharmacology and therapeutics,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
January 2023,
Leukemia research reports,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
January 1998,
Pediatric hematology and oncology,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
January 1971,
La Pediatria,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
January 1976,
Medecine interne,
M Wlazłowski, and
W Celińska, and
L Maciejka-Kapuścińska, and
A Płoszyńska, and
E Idczak
August 2022,
Pediatric research,
